Osteoporosis medications in patients with kidney disease - Clinical Advisor PDF Print
Clinical Advisor
To minimize the risk of chronic kidney disease (CKD) progressing to end-stage renal disease (ESRD), such osteoporosis medications as alendronate (Fosamax) and ibandronate (Boniva) are contraindicated in individuals whose glomerular filtration rate

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.